MedPath

Anxiety and Fear of Cancer Before and After Banding Without Resection in Small SET Management (QUALI-BANDING-SET)

Suspended
Conditions
Gastrointestinal Subepithelial Tumors
Registration Number
NCT04316000
Lead Sponsor
Francesc Bas-Cutrina
Brief Summary

To analyze the hypothetical improvement in anxiety degree, quality of life and fear of cancer in patients diagnosed with a small gastrointestinal subeptithelial tumor when opting for the removal of the lesion.

Detailed Description

This "Quality of Life" study is directly related to the "BANDING-SET" study (NCT03247231), whose main aim is to analyze the effectiveness and safety of endoscopic band ligation without resection in the small gastrointestinal subepithelial tumours management.

Using three validated tests (Hospital Anxiety and Depression Scale \[HADS\], Cancer Worry Scale \[CWS\] and European Five-Dimension Quality of Live test \[EuroQol-5D\]) patients are evaluated before and after the endoscopic procedure.

Three main groups of patients are presented:

* GROUP A, in which the subephitelial tumour is successfully removed \[hypothesis: anxiety and fear of cancer should decrease\].

* GROUP B, in which the subephitelial tumour is not successfully removed due to various reasons (size \>15-mm, not technical success,...) \[hypothesis: anxiety and fear of cancer shuold be similar before-after\].

* GROUP C, in which the subephitelial tumour is not observed or is a benign entity, which does not require further interventions for these patients \[hypothesis: anxiety and fear of cancer should decrease\].

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Initial Fear of Cancer degree1-2 months

At 1-2 months, number of patients with a total fear of cancer score of 11 or more points in the Cancer Worry Scale (CWS).

Cancer Worry Scale (CWS) legend:

* 6-10 points: Low.

* 11-15 points: Moderate.

* 16-20 points: High.

* 21-24 points: Very high.

Initial Anxiety degree1-2 months

At 1-2 months, number of patients with a total anxiety score of 8 or more points in the Hospital Anxiety and Depression Scale (HADS), anxiety subescale.

Hospital Anxiety and Depression Scale (HADS), anxiety subescale, legend:

* 0-7 points: Normal.

* 8-10 points: Borderline anxiety.

* 11-21 points: Anxiety disorder.

Secondary Outcome Measures
NameTimeMethod
Long-term Anxiety degree1 year

At 1 year, number of patients with a total anxiety score of 8 or more points in the Hospital Anxiety and Depression Scale (HADS), anxiety subescale.

Hospital Anxiety and Depression Scale (HADS), anxiety subescale, legend:

* 0-7 points: Normal.

* 8-10 points: Borderline anxiety.

* 11-21 points: Anxiety disorder.

Long-term Fear of Cancer degree1 year

At 1 year, number of patients with a total fear of cancer score of 11 or more points in the Cancer Worry Scale (CWS).

Cancer Worry Scale (CWS) legend:

* 6-10 points: Low.

* 11-15 points: Moderate.

* 16-20 points: High.

* 21-24 points: Very high.

Trial Locations

Locations (7)

Hospital Universitari Germans Trias i Pujol (Can Ruti)

🇪🇸

Badalona, Barcelona, Catalonia, Spain

Hospital Universitari de Bellvitge

🇪🇸

L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain

Hospital Universitari Mútua de Terrassa

🇪🇸

Terrassa, Barcelona, Catalonia, Spain

Hospital de Sant Pau i de la Santa Creu

🇪🇸

Barcelona, Catalonia, Spain

Hospital Universitari de Girona Doctor Josep Trueta

🇪🇸

Girona, Catalonia, Spain

Hospital Universitari Arnau de Vilanova de Lleida

🇪🇸

Lleida, Catalonia, Spain

Hospital Universitari Joan XXIII de Tarragona

🇪🇸

Tarragona, Catalonia, Spain

Hospital Universitari Germans Trias i Pujol (Can Ruti)
🇪🇸Badalona, Barcelona, Catalonia, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.